24
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Beyond Biology: The Crucial Role of Sex and Gender in Oncology

      Submit here before July 31, 2024

      About Oncology Research and Treatment: 2.4 Impact Factor I 3.3 CiteScore I 0.495 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Burkitt's Lymphoma Presenting as Late-Onset Posttransplant Lymphoproliferative Disorder following Kidney and Pancreas Transplantation: Case Report and Review of the Literature

      case-report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Posttransplant lymphoproliferative disorders (PTLD) are a rare, but serious complication following transplantation. Late-onset PTLD are often associated with more monoclonal lesions and consequently have a worse prognosis. There are only isolated case reports of Burkitt's lymphoma presenting as PTLD. We present an extremely rare, aggressive Burkitt's lymphoma years after kidney and pancreas transplantation which was successfully treated with combination chemotherapy along with withdrawal of immunosuppression. The patient remains in complete remission more than 2 years after his diagnosis. We also provide a succinct review of treatment of various PTLD and discuss the role of Epstein-Barr virus infection in the pathogenesis of PTLD.

          Related collections

          Author and article information

          Journal
          Case Rep Oncol
          Case Rep Oncol
          CRO
          Case Reports in Oncology
          S. Karger AG (Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch )
          1662-6575
          Jan-Apr 2013
          8 January 2013
          8 January 2013
          : 6
          : 1
          : 6-14
          Affiliations
          [1] a Blood and Marrow Transplantation, Division of Hematology and Oncology, University School of Medicine, Winston-Salem, N.C., USA
          [2] b Department of Pathology, Wake Forest Baptist Medical Center, University School of Medicine, Winston-Salem, N.C., USA
          [3] c Wake Forest University School of Medicine, Winston-Salem, N.C., USA
          [4] d Department of Molecular Genetics, Wake Forest University School of Medicine, Winston-Salem, N.C., USA
          Author notes
          *Assist. Prof. Seema Naik, MD, Blood and Marrow Transplantation, Division of Hematology and Oncology, Wake Forest Baptist Medical Center, Winston-Salem, NC 27157 (USA), E-Mail s.g.naik@ 123456hotmail.com
          Article
          cro-0006-0006
          10.1159/000346346
          3573821
          23466659
          ea1a20cf-efdc-4113-a6a3-a60e932da041
          Copyright © 2013 by S. Karger AG, Basel

          This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License ( http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.

          History
          Page count
          Figures: 6, References: 17, Pages: 9
          Categories
          Published online: January, 2013

          Oncology & Radiotherapy
          burkitt's lymphoma,epstein-barr virus,posttransplant lymphoproliferative disorders,immunosuppression,b-cell lymphoma 2

          Comments

          Comment on this article